Display Settings:

Format

Send to:

Choose Destination
    Biochem Biophys Res Commun. 2009 Feb 13;379(3):785-9. Epub 2009 Jan 4.

    Breast cancer cell response to genistein is conditioned by BRCA1 mutations.

    Source

    Centre Jean Perrin, Département d'Oncogénétique, 58 rue Montalembert, Clermont-Ferrand Cedex 01, France.

    Abstract

    Soy phytoestrogens, among which genistein, seem to protect from breast cancer development. In order to study the role of the breast tumour suppressor BRCA1 in response to genistein, we used a new breast cancer cell model: the SUM1315MO2 cell line carrying the 185delAG BRCA1 mutation, which we stably transfected with a plasmid encoding wild-type BRCA1. We showed that growth of BRCA1 mutant cells was strongly inhibited by genistein whereas it only had a weak effect in cells expressing wild-type BRCA1 protein. BRCA1 mutant cells hypersensitivity could be linked to higher expression of ERbeta gene, which suggests that genistein may be an efficient inhibitor of cancer development in BRCA1 mutant breast cancer cells.

    PMID:
    19126406
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk